· Selection of the development of vaccine commercialization technology project by Ministry of Health Welfare

· Completion of Osong Bio Plant (GMP facility) Construction

· KIAT 2020 BIG3 SMEs selection of innovative growth support tasks

· Development of Prime-Boost TB vaccines by Chungnam National University, Yonsei University, Quratis and Institut Pasteur were selected as project supported by RIGHT Fund

· Selection of industry-academic Collabo R&D project by Ministry of SMEs and Startups

· Selection of startup scale-up package by Ministry of SMEs and Startups

· Capital increase KRW 10.84 Billion

· Phase 1 TB vaccine in adolescents: interim results completed

· Selection of research driven hospital promotion R&D project by Ministry of Health Welfare

· 2019 Grand Prize for Technology Innovation from Minister,
Ministry of SMEs and Startups

· 2019 Grand Prize for Bio from Ministry of Trade,
Industry and Energy

· Selection of a porcine circovirus vaccine development
project proposed by the Seoul Business Agency

· Phase 2a TB vaccine in adults: interim results completed

· Selection of antibiotic-resistant antimicrobial agent project
supported by the Ministry of SMEs and Startups

· Start of Osong plant construction

· Selection of formulation development project in Cheombok Complex

· Phase 1 IND approval for TB vaccine for adolescents

· Phase 1 IND application for TB vaccine for adolescents

· Capital increase KRW 2 Billion

· Selection of KIT safety pharmacology test project

· Plant site purchase agreement in Osong

· Phase 2a IND approval for TB vaccine for adults

· Capital increase KRW 1.8 Billion

· Phase 2a IND application for TB vaccine for adults

· Finalization of Licensing Agreement with IDRI

· Capital increase KRW 1.1 Billion

· Accredited as a Research Center by the Ministry of Health & Welfare

· Establishment of a R&D Center

· Establishment of Quratis Inc